Charles River Laboratories International, Inc. (CRL) Stock Forecast
CRL analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.33 / 5 from 18 analysts
- Price target
- $315.53 average of analyst targets
- Upside to target
- +5.1% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $2.98
- 52-week range
- $149.93 – $310.77
CRL analyst ratings
18 analystsNumber of analysts at each rating.
CRL price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CRL earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.98 | $2.93 | $3.09 | $2.43 | +22.5% | 13 |
| Current fiscal year (2026) | $11.38 | $11.02 | $11.49 | $10.28 | +10.7% | 17 |
| Next fiscal year (2027) | $12.76 | $11.90 | $13.68 | $11.38 | +12.1% | 17 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CRL revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $960.7M | $951.3M | $984.2M | −4.4% | 11 |
| Current fiscal year (2026) | $3.92B | $3.90B | $3.96B | −2.5% | 14 |
| Next fiscal year (2027) | $4.02B | $3.93B | $4.10B | +2.5% | 15 |
CRL EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CRL revenue: reported and forecast
CRL EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $3.05 | $2.95 | $2.95 | $2.97 | $2.98 | −2.3% | 4 up · 2 down |
| Current fiscal year (2026) | $11.10 | $11.32 | $11.32 | $11.36 | $11.38 | +2.5% | 5 up · 3 down |
| Next fiscal year (2027) | $12.33 | $12.69 | $12.69 | $12.78 | $12.76 | +3.5% | 6 up · 3 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CRL earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CRL beat in 12 of 12.
What analysts expect from CRL
18 analysts cover Charles River; their consensus rating is buy (4.33 on a 1–5 scale, where 5 is a strong buy). The average price target is $315.53, 5.1% above the latest close of $300.15. Analysts expect earnings of $11.38 per share for 2026, +10.7% from a year earlier. For 2027 the average estimate is $12.76 per share on revenue of $4.0 billion. Charles River beat the EPS estimate in 12 of the last 12 quarters.
Related: CRL income statement, CRL key metrics, CRL chart. See the CRL stock overview for the latest quote and news.
CRL forecast FAQ
What is Charles River's price target?
The average analyst price target for Charles River is $315.53, 5.1% above the latest close of $300.15.
Is Charles River a buy, hold or sell?
Of 18 analysts covering Charles River, 11 rate it a strong buy, 4 a buy, 2 a hold, 0 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Charles River's EPS forecast?
Analysts forecast $11.38 per share for 2026 (range $11.02 to $11.49); for 2027 the estimate is $12.76.
What is Charles River's revenue forecast?
The average revenue estimate for 2026 is $3.9 billion, growth of −2.5%; for 2027 it is $4.0 billion.
When does Charles River report earnings?
Charles River is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $2.98.
Does Charles River usually beat earnings estimates?
Charles River reported EPS at or above the analyst estimate in 12 of the last 12 quarters.